EmPhAsIS: Empowering Pharmacists in Asthma Management Through Interactive SMS
- Conditions
- Asthma
- Interventions
- Other: Usual careOther: Interactive SMS
- Registration Number
- NCT02170883
- Lead Sponsor
- University of British Columbia
- Brief Summary
Between 8% and 12% of Canadians suffer from asthma. Although there are effective and inexpensive treatments, adherence to asthma treatment is amongst the lowest for all chronic diseases.The purpose of this study is to determine whether enhancing the role of community pharmacists in asthma management using interactive short messaging service (SMS) with asthma patients is a cost-effective model that will improve adherence to inhaled corticosteroid medications compared to usual care.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 271
- individuals who fill a (incident or prevalent) prescription for inhaled corticosteroids (either monotherapy or in combination inhaler with long-acting beta-agonists) who have been diagnosed by a doctor as having asthma
- possessing a cell-phone with ability to send/receive text messages
- residing in British Columbia (BC), Canada and planning to reside in BC for the next 12 months
- registered with the medical services plan (MSP, the provincial insure of medically-required services) in the past 12 months, and planning to remain registered for the next 12 months
- designated pharmacy being the main drugstore for patient
- not participating in another interventional study
- consent to participate in the study.
- Unable to communicate in English
- Under 14 years of age
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Usual care Usual care Pharmacist conducted patient education, counseling and action-plan Interactive SMS Interactive SMS Intervention with interactive SMS (text messaging) by which patients are asked to disclose their level of agreement with the following statement "I follow my asthma medication plan" and pharmacist follow-up
- Primary Outcome Measures
Name Time Method Adherence to inhaled corticosteroid medication 12 months Adherence assessed by medication possession ratio
- Secondary Outcome Measures
Name Time Method Asthma control 12 months Asthma control assessed by the Asthma Control Test
Quality of life measured by the Asthma Quality of Life Questionnaire 12 months Quality of life measured by the Asthma Quality of Life Questionnaire
Health care resource utilization 12 months Asthma-related hospital admissions and emergency department visits
Use of reliever medication for acute asthma attacks 12 months Use of reliever medication for acute asthma attacks
Trial Locations
- Locations (1)
UBC
🇨🇦Vancouver, British Columbia, Canada